103 results on '"Xiao, Roy"'
Search Results
2. Favorable Outcome Perception in Facial Selective Neurectomy
3. Payer-Negotiated Prices for Cardiac Electrophysiology Procedures at 2022-2023 Top 100 US News & World Report for Cardiology and Heart Surgery Hospitals
4. Osteotomies and Dorsal Hump Reduction in Rhinoplasty: Review of Techniques and Complications
5. Data from Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
6. Supplemental Figure 2 from Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
7. Supplemental Figure 4 from Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
8. Supplemental Figure 2 from Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
9. Supplemental Figure 4 from Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
10. Data from Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
11. Supplementary Table 1 and Supplemental Figure Legends from Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
12. Supplemental Figure 3 from Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
13. Supplemental Figure 1 from Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
14. Supplemental Figure 3 from Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
15. Supplemental Figure 1 from Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
16. Supplementary Table 1 and Supplemental Figure Legends from Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
17. Supplementary Data from Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV− and HPV+ Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy
18. Long-Term Outcome of Patients with Sinonasal Adenoid Cystic Carcinoma and Adenocarcinoma
19. Variations in Payer-Negotiated Prices for Endoscopic Endonasal Skull Base Surgery
20. Practice Patterns of Surgical Approaches for Pituitary Tumors across Otolaryngologists and Neurosurgeons between 2010 and 2018
21. Hospital‐Negotiated Pricing of Cochlear Implants
22. Facial Nerve Exploration for Known or Suspected Transection: The Massachusetts Eye and Ear Experience
23. Payer-negotiated pricing of the hypoglossal nerve stimulator
24. Health Utility Measures Among Patients with Androgenetic Alopecia After Hair Transplant
25. Hospital Prices for Pediatric Tympanostomy Tube Placement and Adenotonsillectomy in 2021
26. Variation in the Price of Head and Neck Surgical Oncology Procedures
27. Hospital-Administered Cancer Therapy Prices for Patients With Private Health Insurance
28. Rhinoplasty Patients Do Not Have Higher Rates of Antidepressant, Anxiolytic, and ADHD Medication Use
29. Out‐of‐pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the Medicare population
30. Payer-Negotiated Prices for Telemedicine Services
31. Private payer‐negotiated prices for FDA‐approved biologic treatments for allergic diseases
32. Spending and Utilization on Drugs Prescribed by Otolaryngologists to Medicare Beneficiaries, 2013 to 2017
33. Analyzing Charge Data Systematically Overestimates Health Care Costs
34. Private Payer–Negotiated Prices for Outpatient Otolaryngologic Surgery
35. Surprise Billing in Health Care
36. Otolaryngologist Performance in the Merit-Based Incentive Payment System in 2018
37. Payer-Negotiated Prices in the Diagnosis and Management of Thyroid Cancer in 2021
38. Analysis of Price Transparency for Oncologic Surgery Among National Cancer Institute–Designated Cancer Centers in 2020
39. Airborne aerosol olfactory deposition contributes to anosmia in COVID-19
40. Characterization of Functional Dysphonia: Pre‐ and Post‐Treatment Findings
41. Thrombospondin‐4 mediates hyperglycemia‐ and TGF ‐beta‐induced inflammation in breast cancer
42. Incomplete Picture of Otolaryngologist Performance in the Merit-Based Incentive Payment System—Reply
43. Refining Assumptions About Specialty Compensation Rates
44. Price Transparency for COVID-19 Testing Among Top US Hospitals
45. Improving medical student recruitment to neurosurgery
46. CARES Act Provider Relief Fund Aid to Otolaryngologists in Small Practices
47. Telemedicine Services Provided to Medicare Beneficiaries by Otolaryngologists Between 2010 and 2018
48. Comparative Effectiveness Between Primary and Revision Foraminotomy for the Treatment of Lumbar Foraminal Stenosis
49. Suction mitigation of airborne particulate generated during sinonasal drilling and cautery
50. Otolaryngologist Performance in the Merit-Based Incentive Payment System in 2017
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.